Login
$LFMD
$1.82 -$0.03 (1.62%) After hours

$LFMD SEC Filings

Filed On Filing
12 Nov 2026 10-Q
12 Nov 2026 8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +3 more

Third quarter 2026 revenue of $44.6 million; adjusted EBITDA loss of approximately $0.4 million, within the Company’s guidance range of negative $1 million to positive $2 million.

09 Nov 2026 NT 10-Q
07 Oct 2026 SCHEDULE 13G/A
25 Sep 2026 S-8
15 Sep 2026 8-K: Regulation FD Disclosure

Through an exclusive collaboration with LifeMD, eligible AT&T wireless and fiber customers receive a complimentary LifeMD membership, a $228 annual value, with on-demand access to a nationwide virtual care and pharmacy platform.

18 Aug 2026 Form 4: Larovere Joan, Director

Received 35,000 shares as a grant or award

18 Aug 2026 Form 4: Strawn John R Jr, Director

Received 50,000 shares as a grant or award · Received 35,000 shares as a grant or award

13 Aug 2026 Form 4: DiTrolio Joseph, Director

Received 35,000 shares as a grant or award

13 Aug 2026 Form 4/A: Simon Roberto, Director

Received 80,810 shares as a grant or award

13 Aug 2026 Form 4: Simon Roberto, Director

Received 50,000 shares as a grant or award · Received 35,000 shares as a grant or award

13 Aug 2026 Form 4: Macrae Calum Archibald, Director

Received 35,000 shares as a grant or award

05 Aug 2026 10-Q
05 Aug 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Second quarter 2026 revenue of $47.3 million, within the Company’s guidance range of $47 million to $50 million; adjusted EBITDA loss of approximately $3.5 million, improving approximately 21% sequentially.

08 Jul 2026 SCHEDULE 13G
22 Jun 2026 8-K: Regulation FD Disclosure

LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection

03 Jun 2026 Form 4: Sripad Umesh, Chief Technology Officer

Received 75,000 shares as a grant or award

03 Jun 2026 Form 3: Sripad Umesh, Chief Technology Officer

No securities owned

13 May 2026 Form 4: Kavthekar Atul, Chief Financial Officer

Received 337,500 shares as a grant or award

06 May 2026 10-Q

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support